206 related articles for article (PubMed ID: 15054716)
1. [Reversible segmental cerebral vasoconstriction: the value of duplex transcranial Doppler in its diagnosis and follow up].
Rubiera del Fueyo M; Molina Cateriano CA; Arenillas Lara JF; Pelayo Vergara R; Santamarina E; Romero Vidal FJ; Alvarez Sabín J
Rev Neurol; 2004 Mar 16-31; 38(6):530-3. PubMed ID: 15054716
[TBL] [Abstract][Full Text] [Related]
2. Reversible cerebral vasoconstriction syndrome or primary angiitis of the central nervous system?
Gerretsen P; Kern RZ
Can J Neurol Sci; 2007 Nov; 34(4):467-77. PubMed ID: 18062458
[TBL] [Abstract][Full Text] [Related]
3. Transcranial Doppler ultrasonography in intensive care.
Rasulo FA; De Peri E; Lavinio A
Eur J Anaesthesiol Suppl; 2008; 42():167-73. PubMed ID: 18289437
[TBL] [Abstract][Full Text] [Related]
4. Reversible cerebral vasoconstriction syndrome.
Ducros A; Bousser MG
Pract Neurol; 2009 Oct; 9(5):256-67. PubMed ID: 19762885
[TBL] [Abstract][Full Text] [Related]
5. Call-Fleming postpartum angiopathy in the puerperium: a reversible cerebral vasoconstriction syndrome.
Neudecker S; Stock K; Krasnianski M
Obstet Gynecol; 2006 Feb; 107(2 Pt 2):446-9. PubMed ID: 16449143
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
Hänggi D; Beseoglu K; Turowski B; Steiger HJ
Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
[TBL] [Abstract][Full Text] [Related]
7. Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option?
Nowak DA; Rodiek SO; Henneken S; Zinner J; Schreiner R; Fuchs HH; Topka H
Cephalalgia; 2003 Apr; 23(3):218-22. PubMed ID: 12662190
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.
Bouchard M; Verreault S; Gariépy JL; Dupré N
Headache; 2009 Jan; 49(1):142-5. PubMed ID: 18647181
[TBL] [Abstract][Full Text] [Related]
9. Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine.
Elstner M; Linn J; Müller-Schunk S; Straube A
Cephalalgia; 2009 Jun; 29(6):677-82. PubMed ID: 19239677
[TBL] [Abstract][Full Text] [Related]
10. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
11. Reversible cerebral vasoconstriction syndrome identification of prognostic factors.
Robert T; Kawkabani Marchini A; Oumarou G; Uské A
Clin Neurol Neurosurg; 2013 Nov; 115(11):2351-7. PubMed ID: 24021453
[TBL] [Abstract][Full Text] [Related]
12. Transcranial color doppler study for reversible cerebral vasoconstriction syndromes.
Chen SP; Fuh JL; Chang FC; Lirng JF; Shia BC; Wang SJ
Ann Neurol; 2008 Jun; 63(6):751-7. PubMed ID: 18496847
[TBL] [Abstract][Full Text] [Related]
13. Reversible cerebral vasoconstriction syndrome: a rare entity in children presenting with thunderclap headache.
Ghosh PS; Rothner AD; Zahka KG; Friedman NR
J Child Neurol; 2011 Dec; 26(12):1580-4. PubMed ID: 21750351
[TBL] [Abstract][Full Text] [Related]
14. Evaluation function of transcranial two-dimensional and color Doppler ultrasonography (TCCS) for patients with different degrees of cerebral vasospasm before and after the nimodipine treatment.
Wang JL; Li XN; Zhang YH; Li X; Yang YL
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2757-2763. PubMed ID: 28678308
[TBL] [Abstract][Full Text] [Related]
15. Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone.
Hawkes MA; Hlavnicka AA; Wainsztein NA
Neurocrit Care; 2020 Feb; 32(1):348-352. PubMed ID: 31571175
[No Abstract] [Full Text] [Related]
16. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
[TBL] [Abstract][Full Text] [Related]
17. Association between reversible cerebral vasoconstriction syndrome and thrombotic thrombocytopenic purpura.
Paliwal PR; Teoh HL; Sharma VK
J Neurol Sci; 2014 Mar; 338(1-2):223-5. PubMed ID: 24423586
[TBL] [Abstract][Full Text] [Related]
18. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.
Ducros A; Boukobza M; Porcher R; Sarov M; Valade D; Bousser MG
Brain; 2007 Dec; 130(Pt 12):3091-101. PubMed ID: 18025032
[TBL] [Abstract][Full Text] [Related]
19. Reversible cerebral vasoconstriction phenomena following indomethacin administration.
Lambru G; Manzoni GC; Torelli P; Grisendi I; Zanferrari C
Headache; 2011 May; 51(5):813-8. PubMed ID: 21521211
[TBL] [Abstract][Full Text] [Related]
20. Possible overlap between reversible cerebral vasoconstriction syndrome and symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
Forget P; Goffette P; van de Wyngaert F; Raftopoulos C; Hantson P
J Headache Pain; 2009 Aug; 10(4):299-302. PubMed ID: 19381433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
